Protocol - Adipocytokines
Description
This protocol provides instructions for drawing, processing, and storing blood according to the National Health and Nutrition Examination Survey (NHANES). The bioassay of leptin and high molecular weight adiponectin uses commercial ELISA kits.
Specific Instructions
To aid in comparability, the Obesity Working Group recommends that the investigator record the make and manufacturer of equipment used and the repeatability and coefficients of variation for the assay.
Availability
Protocol
The following is a summary version of the full National Health and Nutrition Examination Survey (NHANES) 2007-2008 protocol.
Exclusion Criteria
Persons will be excluded from this component if they:
- report that they have hemophilia, or
- report that they have received cancer chemotherapy in the last 4 weeks.
SP = Sample Person
1. Do you have hemophilia?
1 [ ] Yes
2 [ ] No
7 [ ] Refused
9 [ ] Don’t Know
If the SP answers "Yes," the SP is excluded from the blood draw.
If the SP answers "No" or "Don’t Know," blood is drawn from the SP.
2. Have you received cancer chemotherapy in the past 4 weeks, or do you anticipate such therapy in the next 4 weeks?
1 [ ] Yes
2 [ ] No
7 [ ] Refused
9 [ ] Don’t Know
If the SP answers "Yes," the SP is excluded from the blood draw.
If the SP answers "No" or "Don’t Know," blood is drawn from the SP.
Note from the Obesity/Adiposity Working Group (WG): The investigator should record the reason a person is excluded from the blood draw.
Venipuncture Procedures
Editor’s Note: Please review chapter 4 of the Laboratory Procedures Manual from the NHANES for a full description of phlebotomy procedures: 2007-2008 NHANES Lab Manual.
Venipuncture should generally be performed using the median cubital, cephalic, or basilica veins in the left arm unless this arm is unsuitable. If the veins in the left arm are unsuitable, look for suitable veins on the right arm. If the veins in the antecubital space on both arms are not suitable, then look for veins in the forearm or dorsal side of the hand on the left arm/hand and then right arm/hand.
Recording the Results of the Venipuncture Procedure
Immediately after completing the venipuncture, record the results of the blood draw, the reasons for a tube not being drawn according to the protocol, and any comments about the venipuncture.
Note from the Obesity/Adiposity WG: The investigator should record whether the blood was drawn and whether the full amount was obtained.
Process the Sample for the Serum
Editor’s Note: Please review chapter 8 of the Laboratory Procedures Manual from the NHANES 2007-2008 for a full description of blood processing procedures: 2007-2008 NHANES Lab Manual.
- Allow the blood to clot by setting aside for 30-45 minutes at room temperature. Do not clot for more than 1 hour.
- Centrifuge the tube at room temperature to separate the serum and aliquot into an appropriate storage tube.
- Determine if the serum is hemolyzed, turbid, lipemic, or icteric. If so, enter a comment to describe the plasma
Laboratory Assay for Adipocytokines
There are now many laboratory assays that have been approved by the U.S. Food and Drug Administration (FDA). Once an assay is chosen for a particular study, the WG recommends that consistent methods are followed so that assay results will be comparable.
Personnel and Training Required
Certified phlebotomist
Laboratory capable of performing required assays
Equipment Needs
Phlebotomy supplies
Requirements
Requirement Category | Required |
---|---|
Major equipment | No |
Specialized training | No |
Specialized requirements for biospecimen collection | No |
Average time of greater than 15 minutes in an unaffected individual | No |
Mode of Administration
Bioassay
Lifestage
Child, Adolescent, Adult
Participants
All ages: Child-adult
Selection Rationale
Adipocytokines reflect consequential pathways of adiposity. The ELISA method has high feasibility, relatively low cost, and low subject burden.
Language
English
Standards
Standard | Name | ID | Source |
---|---|---|---|
Human Phenotype Ontology | Obesity | HP:0001513 | HPO |
caDSR Form | PhenX PX230201 - Adipocytokines | 6872850 | caDSR Form |
Derived Variables
None
Process and Review
Not applicable.
Protocol Name from Source
National Health and Nutrition Examination Survey Questionnaire (NHANES), Laboratory Procedures Manual, 2007
Source
Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS) (2007). National Health and Nutrition Examination Survey Questionnaire. Laboratory Procedures Manual. Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention.
General References
www.emdmillipore.com/US/en/product/Human-Adiponectin-ELISA,MM_NF-EZHADP-61K
www.emdmillipore.com/US/en/product/Human-Leptin-%22Dual-Range%22-ELISA,MM_NF-EZHL-80SK
Protocol ID
230201
Variables
Export VariablesVariable Name | Variable ID | Variable Description | dbGaP Mapping | |
---|---|---|---|---|
PX230201_Adipocytokines_Assay_Repeatability | ||||
PX230201080000 | Repeatability of the assay | N/A | ||
PX230201_Adipocytokines_Assay_Results | ||||
PX230201100000 | Adipocytokines assay results | N/A | ||
PX230201_Adipocytokines_Assay_Type | ||||
PX230201060000 | Record the type of assay used for more | N/A | ||
PX230201_Adipocytokines_Blood_Draw_Comments | ||||
PX230201040200 | Record any comments about the blood draw, more | N/A | ||
PX230201_Adipocytokines_Blood_Draw_Done | ||||
PX230201040000 | Was blood drawn? | N/A | ||
PX230201_Adipocytokines_Blood_Draw_Sample | ||||
PX230201040100 | Was full amount obtained? | N/A | ||
PX230201_Adipocytokines_Chemotherapy | ||||
PX230201020000 | Have you received cancer chemotherapy in the more | N/A | ||
PX230201_Adipocytokines_Coefficient_Of_Variation | ||||
PX230201090000 | Coefficient of variation for the assay | N/A | ||
PX230201_Adipocytokines_Equipment_Make | ||||
PX230201070100 | Make of the equipment used to perform the more | N/A | ||
PX230201_Adipocytokines_Equipment_Manufacturer | ||||
PX230201070200 | Manufacturer of the equipment used to more | N/A | ||
PX230201_Adipocytokines_Exclusion_Criteria | ||||
PX230201030000 | Exclusion Criteria | N/A | ||
PX230201_Adipocytokines_Hemophilia | ||||
PX230201010000 | Do you have hemophilia? (exclusion from more | N/A | ||
PX230201_Adipocytokines_Sample_Comments | ||||
PX230201050000 | Record any comments about the sample during more | N/A |
Measure Name
Adipocytokines
Release Date
September 9, 2015
Definition
These are bioassays to measure high molecular weight adiponectin.
Purpose
Leptin human ELISA kits are designed to quantify protein levels of human leptin in serum, plasma, supernatant, and other biological fluids. Leptin is a hormone secreted by adipocytes.
Adiponectin is another adipocyte-specific protein which plays a role in the development of insulin resistance and atherosclerosis. HMW adiponectin is the primary bioactive form with insulin-sensitizing activity and is recommended for measurement. Its circulating levels negatively correlate with obesity, insulin resistance, and coronary artery disease.
Keywords
Adipocytokines, leptin, adiponectin, high molecular weight adiponectin, HMWA, obesity, insulin resistance, National Health and Nutrition Examination Survey, NHANES
Measure Protocols
Protocol ID | Protocol Name |
---|---|
230201 | Adipocytokines |
Publications
There are no publications listed for this protocol.